PYXS
Pyxis Oncology Inc
2.90$
-2.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | – | – | 100.0% | – | 100.0% | – | 100.0% | – | – | 100.0% | |
| – | 22.3% | 2.9% | – | – | 50.0% | – | 19.0% | – | -3.9% | – | – | – | |
| – | 77.7% | 97.1% | – | – | 50.0% | – | 100.0% | – | 103.9% | – | – | – | |
| – | 339.4% | 80.7% | – | – | 412.2% | – | 607.6% | – | 196.7% | – | – | 681.0% | |
| – | 180.1% | 51.1% | – | – | 149.4% | – | 192.8% | – | 47.4% | – | – | 228.3% | |
| – | 519.5% | 131.8% | – | – | 1,177.8% | – | 800.4% | – | 269.7% | – | – | 934.2% | |
| – | -519.5% | -34.7% | – | – | -1,177.8% | – | -700.4% | – | -165.7% | – | – | -834.4% | |
| – | 50.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -456.1% | -20.2% | – | – | -1,109.2% | – | -640.8% | – | -154.0% | – | – | -793.8% | |
| – | 113.7% | 6.6% | – | – | -63.6% | – | 10.0% | – | 10.0% | – | – | – | |
| – | -456.1% | -20.2% | – | – | -1,045.6% | – | -650.9% | – | -164.0% | – | – | -803.8% | |
| – | -435.9% | -13.3% | – | – | -545.4% | – | -621.8% | – | -127.9% | – | – | -755.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.